The U.K. NorthStar Clinical Network

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

June 30, 2025

Conditions
Duchenne Muscular Dystrophy
Trial Locations (26)

Unknown

Aberdeen, NHS Grampian, Aberdeen

Belfast Health and Social Care Trust, Belfast

Birmingham Children's Hospital, Birmingham

Birmingham Community Healthcare NHS Foundation Trust, Birmingham

Birmingham Heartlands Hospital, Birmingham

University Hospitals Bristol and Weston, Bristol

Cambridge University Hospitals, Cambridge

Cardiff and Vale University Health Board, Cardiff

NHS Dundee - Tayside, Dundee

NHS Greater Glasgow and Clyde, Glasgow

Lancashire Teaching Hospitals NHS Foundation Trust, Lancaster

Leeds Teaching Hospitals NHS Trust, Leeds

University Hospitals of Leicester NHS Trust, Leicester

Alder Hey Children's Hospital Trust, Liverpool

Evelina London Children's Hospital, London

Great Ormond Street Hospital for Children NHS Foundation Trust, London

Manchester University NHS Foundation Trust, Manchester

Newcastle Hospitals NHS Foundation Trust, Newcastle

Nottingham University Hospitals NHS Trust, Nottingham

The Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry

Oxford University Hospitals, Oxford

University Hospitals Plymouth NHS Trust, Plymouth

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

University Hospital Southampton NHS Foundation Trust, Southampton

Swansea Bay University Health Board, Swansea

WC1N 3BH

Great Ormond Street Hospital for Children NHS Foundation Trust, London

All Listed Sponsors
collaborator

Muscular Dystrophy UK

UNKNOWN

lead

University College, London

OTHER

NCT06711692 - The U.K. NorthStar Clinical Network | Biotech Hunter | Biotech Hunter